http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7090841-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2001-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d835988b1651abaf7ad3a96a48d6776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f1afb2d201b656227d964721d4490d |
| publicationDate | 2006-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-7090841-B1 |
| titleOfInvention | Use of CD63 inhibitors |
| abstract | The invention provides a method of decreasing human immunodeficiency virus entry into cells, the method comprising decreasing levels of functional CD63 present with the human immunodeficiency virus and the cells. The invention further provides a method of treating or preventing human immunodeficiency virus infection in a subject, the method comprising administering to the subject an amount of a compound effective to decrease levels of functional CD63 in the cells of the subject. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009186819-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008199457-A1 |
| priorityDate | 2000-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.